Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression

Alessia Cimadamore, Silvia Gasparrini, Roberta Mazzucchelli, Andrea Doria, Liang Cheng, Antonio Lopez-Beltran, Matteo Santoni, Marina Scarpelli, Rodolfo Montironi

Research output: Contribution to journalShort survey

9 Citations (Scopus)

Abstract

Long non-coding RNAs (lncRNAs) are a class of RNA with transcripts longer than 200 nucleotides that lack functional open reading frames. They play various roles in human carcinoma, such as dysregulating gene expression in prostate cancer (PCa), which results in cancer initiation, development, and progression. The non-coding RNA SChLAP1 (second chromosome locus associated with prostate-1) is highly expressed in approximately 25% of PCas with higher prevalence in metastatic compared to localized PCa. Its expression is detectable non-invasively in PCa patient urine samples. Experimental data suggest that targeting SChLAP1 may represent a novel therapeutic application in PCa. This contribution focuses on the role of lncRNAs SChLAP1 expression in PCa diagnosis and prognosis.

Original languageEnglish (US)
Article number305
JournalFrontiers in Oncology
Volume7
Issue numberDEC
DOIs
StatePublished - Dec 12 2017

Fingerprint

Long Noncoding RNA
Prostate
Prostatic Neoplasms
Chromosomes
Untranslated RNA
Open Reading Frames
Nucleotides
Urine
RNA
Carcinoma
Gene Expression
Neoplasms

Keywords

  • Lethal prostate cancer
  • Long non-coding RNA
  • Marker of aggressiveness
  • Metastatic prostate cancer
  • Prognostic biomarker
  • Second chromosome locus associated with prostate-1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression. / Cimadamore, Alessia; Gasparrini, Silvia; Mazzucchelli, Roberta; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Santoni, Matteo; Scarpelli, Marina; Montironi, Rodolfo.

In: Frontiers in Oncology, Vol. 7, No. DEC, 305, 12.12.2017.

Research output: Contribution to journalShort survey

Cimadamore, A, Gasparrini, S, Mazzucchelli, R, Doria, A, Cheng, L, Lopez-Beltran, A, Santoni, M, Scarpelli, M & Montironi, R 2017, 'Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression', Frontiers in Oncology, vol. 7, no. DEC, 305. https://doi.org/10.3389/fonc.2017.00305
Cimadamore, Alessia ; Gasparrini, Silvia ; Mazzucchelli, Roberta ; Doria, Andrea ; Cheng, Liang ; Lopez-Beltran, Antonio ; Santoni, Matteo ; Scarpelli, Marina ; Montironi, Rodolfo. / Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression. In: Frontiers in Oncology. 2017 ; Vol. 7, No. DEC.
@article{c4db96e78d0a4ebfbdb84ef175f59f5b,
title = "Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression",
abstract = "Long non-coding RNAs (lncRNAs) are a class of RNA with transcripts longer than 200 nucleotides that lack functional open reading frames. They play various roles in human carcinoma, such as dysregulating gene expression in prostate cancer (PCa), which results in cancer initiation, development, and progression. The non-coding RNA SChLAP1 (second chromosome locus associated with prostate-1) is highly expressed in approximately 25{\%} of PCas with higher prevalence in metastatic compared to localized PCa. Its expression is detectable non-invasively in PCa patient urine samples. Experimental data suggest that targeting SChLAP1 may represent a novel therapeutic application in PCa. This contribution focuses on the role of lncRNAs SChLAP1 expression in PCa diagnosis and prognosis.",
keywords = "Lethal prostate cancer, Long non-coding RNA, Marker of aggressiveness, Metastatic prostate cancer, Prognostic biomarker, Second chromosome locus associated with prostate-1",
author = "Alessia Cimadamore and Silvia Gasparrini and Roberta Mazzucchelli and Andrea Doria and Liang Cheng and Antonio Lopez-Beltran and Matteo Santoni and Marina Scarpelli and Rodolfo Montironi",
year = "2017",
month = "12",
day = "12",
doi = "10.3389/fonc.2017.00305",
language = "English (US)",
volume = "7",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "DEC",

}

TY - JOUR

T1 - Long Non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression

AU - Cimadamore, Alessia

AU - Gasparrini, Silvia

AU - Mazzucchelli, Roberta

AU - Doria, Andrea

AU - Cheng, Liang

AU - Lopez-Beltran, Antonio

AU - Santoni, Matteo

AU - Scarpelli, Marina

AU - Montironi, Rodolfo

PY - 2017/12/12

Y1 - 2017/12/12

N2 - Long non-coding RNAs (lncRNAs) are a class of RNA with transcripts longer than 200 nucleotides that lack functional open reading frames. They play various roles in human carcinoma, such as dysregulating gene expression in prostate cancer (PCa), which results in cancer initiation, development, and progression. The non-coding RNA SChLAP1 (second chromosome locus associated with prostate-1) is highly expressed in approximately 25% of PCas with higher prevalence in metastatic compared to localized PCa. Its expression is detectable non-invasively in PCa patient urine samples. Experimental data suggest that targeting SChLAP1 may represent a novel therapeutic application in PCa. This contribution focuses on the role of lncRNAs SChLAP1 expression in PCa diagnosis and prognosis.

AB - Long non-coding RNAs (lncRNAs) are a class of RNA with transcripts longer than 200 nucleotides that lack functional open reading frames. They play various roles in human carcinoma, such as dysregulating gene expression in prostate cancer (PCa), which results in cancer initiation, development, and progression. The non-coding RNA SChLAP1 (second chromosome locus associated with prostate-1) is highly expressed in approximately 25% of PCas with higher prevalence in metastatic compared to localized PCa. Its expression is detectable non-invasively in PCa patient urine samples. Experimental data suggest that targeting SChLAP1 may represent a novel therapeutic application in PCa. This contribution focuses on the role of lncRNAs SChLAP1 expression in PCa diagnosis and prognosis.

KW - Lethal prostate cancer

KW - Long non-coding RNA

KW - Marker of aggressiveness

KW - Metastatic prostate cancer

KW - Prognostic biomarker

KW - Second chromosome locus associated with prostate-1

UR - http://www.scopus.com/inward/record.url?scp=85037979493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037979493&partnerID=8YFLogxK

U2 - 10.3389/fonc.2017.00305

DO - 10.3389/fonc.2017.00305

M3 - Short survey

AN - SCOPUS:85037979493

VL - 7

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - DEC

M1 - 305

ER -